3rd Quarter - Report
OGR for MILLENNIUM PHARMACEUTICALS INC
Firm
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007. Issues related to Medicare coverage for certain cancer therapies. Issues related to Comparative Effectiveness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOSES MERCADO | — |
| ANDREW ROSENBERG | — |
| GORDON TAYLOR | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.